Logo image of ACON

ACLARION INC (ACON) Stock Price, Quote, News and Overview

NASDAQ:ACON - Nasdaq - US6551873002 - Common Stock - Currency: USD

7.51  -0.13 (-1.7%)

After market: 7.45 -0.06 (-0.8%)

ACON Quote, Performance and Key Statistics

ACLARION INC

NASDAQ:ACON (4/25/2025, 8:00:00 PM)

After market: 7.45 -0.06 (-0.8%)

7.51

-0.13 (-1.7%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
Statistics
52 Week High3499.51
52 Week Low7.26
Market Cap4.36M
Shares580.00K
Float580.00K
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO04-22 2022-04-22


ACON short term performance overview.The bars show the price performance of ACON in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

ACON long term performance overview.The bars show the price performance of ACON in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of ACON is 7.51 USD. In the past month the price decreased by -46.71%. In the past year, price decreased by -99.75%.

ACLARION INC / ACON Daily stock chart

ACON Competitors/Peers

The largest stocks on the US markets in the "Health Care Technology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
VEEV VEEVA SYSTEMS INC-CLASS A 34.42 37.02B
DOCS DOXIMITY INC-CLASS A 44.26 10.63B
WAY WAYSTAR HOLDING CORP N/A 6.37B
CERT CERTARA INC 31.49 2.29B
SDGR SCHRODINGER INC N/A 1.93B
GDRX GOODRX HOLDINGS INC-CLASS A 14.18 1.80B
PHR PHREESIA INC N/A 1.45B
TDOC TELADOC HEALTH INC N/A 1.26B
LFMDP LIFEMD INC - LFMD 8 7/8 PERP N/A 1.06B
EVH EVOLENT HEALTH INC - A 13.61 1.05B
HSTM HEALTHSTREAM INC 50.42 1.02B
CCLDO CARECLOUD INC - CCLD 8 3/4 PERP N/A 771.92M

About ACON

Company Profile

ACON logo image Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. The company is headquartered in Broomfield, Colorado and currently employs 6 full-time employees. The company went IPO on 2022-04-22. The firm leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. The company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that the Company has demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. The company uses a magnet to apply a pulsed magnetic field to a patient, sensors to detect radio waves that emanate from the resonant vibrations of different chemicals in the body in response to that pulsed magnetic field and a computer to create detailed images of tissue structures in the patient based on those detected chemical signals.

Company Info

ACLARION INC

8181 Arista Place, Ste 100

Broomfield COLORADO US

Employees: 5

Company Website: https://aclarion.com/

Investor Relations: https://investors.aclarion.com/

Phone: 18332752266

ACLARION INC / ACON FAQ

What is the stock price of ACLARION INC today?

The current stock price of ACON is 7.51 USD. The price decreased by -1.7% in the last trading session.


What is the ticker symbol for ACLARION INC stock?

The exchange symbol of ACLARION INC is ACON and it is listed on the Nasdaq exchange.


On which exchange is ACON stock listed?

ACON stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ACLARION INC stock?

8 analysts have analysed ACON and the average price target is 11993.7 USD. This implies a price increase of 159603.06% is expected in the next year compared to the current price of 7.51. Check the ACLARION INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ACLARION INC worth?

ACLARION INC (ACON) has a market capitalization of 4.36M USD. This makes ACON a Nano Cap stock.


How many employees does ACLARION INC have?

ACLARION INC (ACON) currently has 5 employees.


Is ACLARION INC (ACON) expected to grow?

The Revenue of ACLARION INC (ACON) is expected to grow by 186.36% in the next year. Check the estimates tab for more information on the ACON EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ACLARION INC (ACON) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ACLARION INC (ACON) stock pay dividends?

ACON does not pay a dividend.


What is the Price/Earnings (PE) ratio of ACLARION INC (ACON)?

ACLARION INC (ACON) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3500.64).


ACON Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ACON Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ACON. The financial health of ACON is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ACON Financial Highlights

Over the last trailing twelve months ACON reported a non-GAAP Earnings per Share(EPS) of -3500.64.


Industry RankSector Rank
PM (TTM) N/A
ROA -197.01%
ROE -250.25%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%-20.29%
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

ACON Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to ACON. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of -71.31% and a revenue growth 186.36% for ACON


Ownership
Inst Owners0%
Ins OwnersN/A
Short Float %N/A
Short Ratio0
Analysts
Analysts80
Price Target11993.7 (159603.06%)
EPS Next Y-71.31%
Revenue Next Year186.36%